+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Wound Closure & Advanced Wound Care Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532908
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Wound Closure & Advanced Wound Care Market grew from USD 17.86 billion in 2024 to USD 19.57 billion in 2025. It is expected to continue growing at a CAGR of 9.51%, reaching USD 30.81 billion by 2030.

Unlocking the Future of Wound Closure and Advanced Healing

Wound closure and advanced wound care have emerged as pivotal components of modern healthcare, driven by the imperative to reduce healing times, prevent complications, and optimize patient outcomes. The convergence of rising chronic disease prevalence, aging populations, and heightened surgical volumes underscores the critical need for innovative products and devices. As healthcare systems worldwide grapple with cost containment and quality improvement, wound management strategies have evolved from basic dressings to sophisticated biologics, tissue-engineered constructs, and advanced negative pressure systems. This executive summary distills the complex interplay of technological breakthroughs, regulatory landscapes, and market forces, offering clarity on emerging trends.

Stakeholders ranging from medical device manufacturers to care providers require a concise yet comprehensive overview of current dynamics. This introduction sets the stage for an in-depth exploration of transformative shifts, tariff impacts, segmentation insights, and regional drivers. By framing the strategic context, we underscore the importance of evidence-based decision-making and collaborative innovation. The objective is to equip industry leaders with actionable intelligence that navigates uncertainties and capitalizes on growth opportunities. In doing so, we illuminate pathways for investment, product development, and market expansion across diverse therapeutic applications and distribution channels.

Evolutionary Forces Reshaping Wound Care Dynamics

The landscape of wound care is undergoing rapid transformation, fueled by technological innovation and evolving patient expectations. Precision therapies such as growth factors and cytokines are now complementing traditional dressings, while cellular constructs harness tissue engineering to jump-start reparative processes. Digital wound monitoring platforms are gaining traction, enabling clinicians to track healing trajectories remotely, reduce hospital visits, and enhance patient engagement. These shifts reflect a broader trend toward personalized, data-driven care.

Regulatory bodies are responding with streamlined pathways for breakthrough devices and biologics, incentivizing research and accelerating time-to-market. Meanwhile, healthcare purchasers are demanding evidence of cost-effectiveness, prompting adoption of value-based reimbursement models. The rise of outpatient procedures and home-based wound management is also reshaping distribution strategies, as providers seek to shift care settings without compromising outcomes. Together, these convergent forces are redefining competitive dynamics, prompting companies to forge partnerships and pursue vertical integration. Understanding these transformative shifts is essential for anticipating future trajectories and positioning products at the forefront of clinical practice.

Navigating the Repercussions of 2025 United States Tariffs

The imposition of revised United States tariffs in 2025 has sent reverberations across the wound closure and advanced care market, affecting both import-dependent manufacturers and end-users. Devices such as negative pressure wound therapy systems and specialized dressings, often sourced from global suppliers, now carry additional cost burdens that are being passed down through supply chains. Manufacturers must reconcile higher input costs with the imperative to maintain competitive pricing, challenging margins and strategic planning.

Beyond immediate financial implications, tariff fluctuations are driving reconfiguration of sourcing strategies. Some organizations are exploring nearshoring to mitigate exposure, while others are renegotiating supplier contracts or investing in domestic production capabilities. This realignment is not confined to devices alone; biologics and cellular products, which frequently traverse multiple countries during production, now face complex customs classifications that can delay distribution. Service providers and healthcare facilities are likewise recalibrating procurement decisions, weighing the tradeoffs between cost, quality, and availability. By understanding the cumulative impact of these tariffs, industry participants can craft resilient strategies that preserve market access and sustain innovation momentum.

Decoding Market Segments for Strategic Advantage

Sophisticated segmentation analysis reveals diverse growth trajectories across product categories and clinical applications. Within the realm of advanced wound care, innovations in negative pressure technology have captured significant interest, while biologics and tissue-engineered therapeutics continue to expand their therapeutic footprint. Dressings ranging from alginate to hydrocolloid remain indispensable in initial wound management, even as the market for film and hydrogel formulations grows in response to patient comfort and moisture-control considerations. In parallel, wound closure devices-spanning adhesives, staples, sutures, and strips-are evolving to enhance procedural efficiency and reduce complication rates.

When considering clinical applications, chronic wounds arising from diabetic ulcers, pressure sores, and venous insufficiency demand long-term care strategies that prioritize cellular regeneration and infection control. Surgical wounds across cardiovascular, orthopedic, general, and cosmetic specialties present unique healing environments that benefit from tailored closure devices and adjunctive therapies. Traumatic injuries such as lacerations and puncture wounds require rapid sealing and protection, often necessitating portable solutions suited for emergency settings. These end-user requirements are reflected in channel dynamics, with hospitals, ambulatory centers, home health providers, and pharmacies each playing distinct roles in product distribution. Recognizing the interplay of product innovation, application demands, end-user preferences, and channel efficiencies is crucial to unlocking new revenue streams.

Regional Trajectories Powering the Global Wound Care Arena

Regional analysis underscores stark contrasts in adoption rates, regulatory frameworks, and reimbursement structures across the Americas, EMEA, and Asia-Pacific. In North America, robust research infrastructure and favorable reimbursement policies have accelerated uptake of advanced therapies, particularly in the biologics and negative pressure segments. Latin American markets, while burgeoning, face challenges such as inconsistent healthcare funding and limited access to premium devices, driving interest in cost-effective alternatives.

Europe’s heterogeneous regulatory environment presents both opportunities and complexities. Countries with centralized approval mechanisms facilitate quicker market entry, whereas others demand extensive clinical validation. Reimbursement mechanisms vary widely, influencing pricing strategies and market penetration. The Middle East and Africa regions are characterized by nascent advanced care adoption, spurring interest from manufacturers seeking to establish early partnerships and capacity-building initiatives. Asia-Pacific markets exhibit dynamic growth, fueled by expanding healthcare infrastructure, rising surgical volumes, and increased government support for domestic production. Tailoring strategies to these regional nuances is essential for capturing share and sustaining long-term success across geographies.

Competitive Landscape and Corporate Momentum

Leading firms in wound closure and advanced care are differentiating through targeted M&A, R&D investment, and strategic alliances. Companies specializing in tissue-engineered products have pursued acquisitions to broaden their pipeline of cellular therapies, while established device manufacturers have formed joint ventures to integrate digital monitoring capabilities. The competitive field also includes nimble startups leveraging novel biomaterials and regenerative approaches, compelling incumbents to accelerate innovation cycles.

Market leaders are optimizing global footprints by aligning manufacturing capacity with demand hubs, enhancing supply chain resilience in the face of tariff uncertainties. Portfolio diversification remains a key strategy, as players expand beyond core sutures and dressings into high-growth segments like growth factors and negative pressure systems. Collaborative research agreements with academic institutions and clinical centers of excellence are yielding compelling clinical data, further strengthening market positioning. By closely monitoring peer activity and technological milestones, stakeholders can identify partnership and investment opportunities that bolster competitive advantage.

Strategic Imperatives for Market Leadership

To thrive amid evolving dynamics, industry leaders must pursue an integrated approach encompassing innovation, agility, and collaboration. Investing in next-generation biologics and digital wound monitoring platforms can unlock premium growth, while expanding or relocating manufacturing assets helps insulate supply chains from tariff-induced disruptions. Companies should pursue strategic collaborations with clinical research centers to generate robust real-world evidence that supports reimbursement negotiations and product differentiation.

Diversification across clinical applications and geographies can mitigate concentration risks, but requires localized market intelligence and tailored engagement strategies for hospitals, ambulatory centers, and home health providers. Embracing value-based care models entails developing outcome-driven solutions and support services that demonstrably reduce total cost of care. Transparent dialogue with payers and regulatory agencies can pave the way for favorable pathways and accelerated approvals. Finally, fostering cross-functional teams that bridge R&D, regulatory, and commercial expertise ensures coherent execution of strategic initiatives and rapid response to emerging market trends.

Rigorous Methodology Underpinning Our Insights

This analysis synthesizes primary interviews with clinical experts, procurement officers, and device innovators alongside secondary research from regulatory filings, peer-reviewed literature, and publicly available financial disclosures. Detailed segmentation frameworks underpin quantitative assessments of product, application, end-user, and distribution channel dynamics. Rigorous validation protocols, including triangulation of multiple data sources and iterative expert reviews, ensure high-confidence insights.

Our methodology emphasizes transparency and reproducibility, with clearly defined inclusion criteria for data sets and a structured approach to forecasting directional trends. Regional evaluations incorporate localized regulatory guidelines and reimbursement schedules. Competitive intelligence is derived from patent analyses, corporate press releases, and strategic filings. Through this multifaceted approach, the findings offer a reliable foundation for strategic planning, investment prioritization, and risk mitigation in the wound closure and advanced wound care market.

Synthesis of Critical Findings and Forward Outlook

This executive summary encapsulates the critical forces reshaping wound closure and advanced wound care, from tariff pressures to segmentation nuances and regional dynamics. The convergence of technological innovation, regulatory evolution, and shifting reimbursement paradigms is creating unprecedented opportunities and challenges. Stakeholders who integrate deep market intelligence with agile execution will be best positioned to drive growth, operational excellence, and patient-centric outcomes.

As the field continues to evolve, sustained investment in R&D, strategic partnerships, and evidence-based value propositions will differentiate winners from laggards. By harnessing the insights presented here, decision-makers can craft strategies that navigate uncertainties, capitalize on high-growth segments, and deliver superior clinical and economic value across diverse care settings.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Advanced Wound Care Products
      • Biologics And Tissue Engineered Products
        • Cellular And Tissue Engineered Products
        • Growth Factors And Cytokines
      • Negative Pressure Wound Therapy
      • Wound Dressings
        • Alginate Dressing
        • Composite Dressing
        • Film And Hydrogel Dressing
        • Foam Dressing
        • Hydrocolloid Dressing
    • Wound Closure Devices And Aids
      • Adhesives
      • Staples
      • Sutures
        • Absorbable Sutures
        • Nonabsorbable Sutures
      • Tapes And Strips
  • Application
    • Chronic Wounds
      • Diabetic Ulcers
      • Pressure Ulcers
      • Venous Ulcers
    • Surgical Wounds
      • Cardiovascular Surgery Wounds
      • Cosmetic Surgery Wounds
      • General Surgery Wounds
      • Orthopedic Surgery Wounds
    • Traumatic Wounds
      • Lacerations
      • Puncture Wounds
  • End User
    • Clinics And Ambulatory Surgery Centers
    • Home Healthcare
    • Hospitals
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Medtronic plc
  • Smith & Nephew plc
  • Stryker Corporation
  • 3M Company
  • Mölnlycke Health Care AB
  • Coloplast A/S
  • ConvaTec Group plc
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Wound Closure & Advanced Wound Care Market, by Product Type
8.1. Introduction
8.2. Advanced Wound Care Products
8.2.1. Biologics And Tissue Engineered Products
8.2.1.1. Cellular And Tissue Engineered Products
8.2.1.2. Growth Factors And Cytokines
8.2.2. Negative Pressure Wound Therapy
8.2.3. Wound Dressings
8.2.3.1. Alginate Dressing
8.2.3.2. Composite Dressing
8.2.3.3. Film And Hydrogel Dressing
8.2.3.4. Foam Dressing
8.2.3.5. Hydrocolloid Dressing
8.3. Wound Closure Devices And Aids
8.3.1. Adhesives
8.3.2. Staples
8.3.3. Sutures
8.3.3.1. Absorbable Sutures
8.3.3.2. Nonabsorbable Sutures
8.3.4. Tapes And Strips
9. Wound Closure & Advanced Wound Care Market, by Application
9.1. Introduction
9.2. Chronic Wounds
9.2.1. Diabetic Ulcers
9.2.2. Pressure Ulcers
9.2.3. Venous Ulcers
9.3. Surgical Wounds
9.3.1. Cardiovascular Surgery Wounds
9.3.2. Cosmetic Surgery Wounds
9.3.3. General Surgery Wounds
9.3.4. Orthopedic Surgery Wounds
9.4. Traumatic Wounds
9.4.1. Lacerations
9.4.2. Puncture Wounds
10. Wound Closure & Advanced Wound Care Market, by End User
10.1. Introduction
10.2. Clinics And Ambulatory Surgery Centers
10.3. Home Healthcare
10.4. Hospitals
11. Wound Closure & Advanced Wound Care Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Wound Closure & Advanced Wound Care Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Wound Closure & Advanced Wound Care Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Wound Closure & Advanced Wound Care Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Smith & Nephew plc
15.3.4. Stryker Corporation
15.3.5. 3M Company
15.3.6. Mölnlycke Health Care AB
15.3.7. Coloplast A/S
15.3.8. ConvaTec Group plc
15.3.9. B. Braun Melsungen AG
15.3.10. Integra LifeSciences Holdings Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. WOUND CLOSURE & ADVANCED WOUND CARE MARKET MULTI-CURRENCY
FIGURE 2. WOUND CLOSURE & ADVANCED WOUND CARE MARKET MULTI-LANGUAGE
FIGURE 3. WOUND CLOSURE & ADVANCED WOUND CARE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. WOUND CLOSURE & ADVANCED WOUND CARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. WOUND CLOSURE & ADVANCED WOUND CARE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. WOUND CLOSURE & ADVANCED WOUND CARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CELLULAR AND TISSUE ENGINEERED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY GROWTH FACTORS AND CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY NEGATIVE PRESSURE WOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ALGINATE DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COMPOSITE DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY FILM AND HYDROGEL DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY FOAM DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY HYDROCOLLOID DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY STAPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY NONABSORBABLE SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TAPES AND STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CARDIOVASCULAR SURGERY WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COSMETIC SURGERY WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY GENERAL SURGERY WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ORTHOPEDIC SURGERY WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY LACERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PUNCTURE WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICS AND AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 82. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 83. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 84. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 85. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 86. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 88. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 89. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 90. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 159. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 162. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 163. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. GERMANY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 168. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 171. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 191. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 192. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 193. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 194. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 195. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 197. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 198. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 199. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ITALY WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 204. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 207. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SPAIN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 252. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 255. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 259. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. DENMARK WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUTURES, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRAUMATIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. QATAR WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. QATAR WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND CARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 275. QATAR WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS AND TISSUE ENGINEERED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 276. QATAR WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND DRESSINGS, 2018-2030 (USD MILLION)
TABLE 277. QATAR WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND CLOSURE DEVICES AND AIDS, 2018-2030 (USD MILLION)
TABLE 278. QATAR WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SUT

Companies Mentioned

The companies profiled in this Wound Closure & Advanced Wound Care market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Smith & Nephew plc
  • Stryker Corporation
  • 3M Company
  • Mölnlycke Health Care AB
  • Coloplast A/S
  • ConvaTec Group plc
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation

Methodology

Loading
LOADING...

Table Information